familial Mediterranean fever
Information
- Disease name
- familial Mediterranean fever
- Disease ID
- DOID:2987
- Description
- "An autoimmune disease characterized by recurrent episodes of fever and acute inflammation of the membranes lining the abdomen, joints and lungs; that has_material_basis_in mutations in the MEFV gene, which encodes the protein pyrin." [url:http\://en.wikipedia.org/wiki/Familial_Mediterranean_fever, url:https\://www.rarediseases.org/rare-disease-information/rare-diseases/byID/127/viewAbstract]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT06257342 | Active, not recruiting | Physical Abilities of Teenagers With Familial Mediterranean Fever | July 30, 2023 | December 31, 2027 | |
NCT00094900 | Completed | Phase 2 | Interleukin-1 Trap to Treat Autoinflammatory Diseases | October 2004 | December 2010 |
NCT00582907 | Completed | Phase 2 | Rilonacept for Treatment of Familial Mediterranean Fever (FMF) | August 2008 | September 2011 |
NCT05177120 | Completed | Central Sensitization in Familial Mediterranean Fever (FMF) | June 1, 2021 | August 3, 2022 | |
NCT03747315 | Completed | A Diagnostic Test for Familial Mediterranean Fever | December 15, 2018 | December 15, 2020 | |
NCT04729218 | Completed | The Movement Imagery Ability in Patients With Familial Mediterranean Fever | January 1, 2018 | February 18, 2021 | |
NCT01075906 | Completed | Phase 1 | Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients | August 2010 | December 2011 |
NCT01088880 | Completed | Phase 2 | Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever | April 2010 | August 2011 |
NCT01705756 | Completed | Phase 3 | Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever | November 2012 | June 2015 |
NCT02602028 | Completed | Phase 4 | The Comparison of the Efficacy of Once and Twice Daily Colchicine Dosage in Pediatric Patients With FMF | April 2011 | August 2013 |
NCT03446209 | Completed | Phase 2 | Tocilizumab for the Treatment of Familial Mediterranean Fever | April 23, 2018 | October 30, 2020 |
NCT06033339 | Not yet recruiting | N/A | Assessment of microRNAs Role in Familial Mediterranean Fever FMF Pathophysiology | October 2, 2023 | October 2, 2025 |
NCT05488561 | Not yet recruiting | N/A | Clinical and Molecular Evaluation of Childern With Familial Meditterranean Fever and Their Siblings | August 15, 2022 | August 2023 |
NCT06338891 | Recruiting | Can Gluten/Wheat or Other Foods be Responsible for FMF Attacks | May 1, 2024 | May 1, 2025 | |
NCT05092776 | Recruiting | Phase 2 | Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine | April 29, 2021 | October 2024 |
NCT05190991 | Recruiting | Phase 2 | Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever | October 5, 2021 | August 2026 |
NCT05596643 | Recruiting | Investigation of Autonomic Dysfunction in Patients With Familial Mediterranean Fever | March 15, 2022 | October 31, 2022 | |
NCT06034795 | Recruiting | Evaluation of Bone Metabolism in Children and Adolescents With Familial Mediterranean Fever | January 8, 2022 | January 2025 | |
NCT01059279 | Terminated | Heat Intolerance in the Group of FMF Patients | December 2009 | March 3, 2024 | |
NCT02175589 | Unknown status | Phase 2 | Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation | June 2014 | January 2015 |
NCT00658060 | Unknown status | Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients | September 2007 | ||
NCT04724993 | Unknown status | N/A | Effects of Online Aerobic Exercise Training and Physical Activity Counseling in Juvenile Familial Mediterranean Fever | December 20, 2020 | December 2021 |
NCT04478409 | Unknown status | Characterization of a Functional Test for Mediterranean Family Fever Screening - 2 | July 21, 2021 | June 2024 | |
NCT00323440 | Withdrawn | Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission | August 2008 | August 2016 | |
NCT05448391 | Withdrawn | Phase 2 | A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF) | September 13, 2022 | December 30, 2024 |
- Disase is a (Disease Ontology)
- DOID:417
- Cross Reference ID (Disease Ontology)
- GARD:6421
- Cross Reference ID (Disease Ontology)
- ICD10CM:M04.1
- Cross Reference ID (Disease Ontology)
- ICD9CM:277.31
- Cross Reference ID (Disease Ontology)
- MESH:D010505
- Cross Reference ID (Disease Ontology)
- MIM:134610
- Cross Reference ID (Disease Ontology)
- MIM:249100
- Cross Reference ID (Disease Ontology)
- NCI:C84707
- Cross Reference ID (Disease Ontology)
- ORDO:342
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:12579009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0031069
- Exact Synonym (Disease Ontology)
- benign paroxysmal peritonitis
- Exact Synonym (Disease Ontology)
- FMF
- OrphaNumber from OrphaNet (Orphanet)
- 342
- MeSH unique ID (MeSH (Medical Subject Headings))
- D010505